Incyte Corporation Profile Avatar - Palmy Investing

Incyte Corporation

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and p…

Biotechnology
US, Wilmington [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 3 6 LDA-2 Oct. 21, 2024, 6:20 p.m.
2024 3 6 LDA-2 Oct. 21, 2024, 6:02 p.m.
2024 3 6 LDA-2 Oct. 15, 2024, 10:51 p.m.
2024 2 6 LDA-2 July 22, 2024, 10:29 p.m.
2024 2 6 LDA-2 July 22, 2024, 9:43 p.m.
2024 2 6 LDA-2 July 15, 2024, 6:05 p.m.
2024 1 6 LDA-2 April 22, 2024, 11:02 p.m.
2024 1 6 LDA-2 April 22, 2024, 8:31 p.m.
2024 1 6 LDA-2 April 12, 2024, 3:18 p.m.
2023 4 6 LDA-2 Jan. 22, 2024, 9:42 p.m.
2023 4 6 LDA-2 Jan. 22, 2024, 6:13 p.m.
2023 4 6 LDA-2 Jan. 17, 2024, 4:43 p.m.
End of INCY's Analysis
CIK: 879169 CUSIP: 45337C102 ISIN: US45337C1027 LEI: - UEI: -
Secondary Listings
INCY has no secondary listings inside our databases.